Kallikrein 15 Antikörper
Kurzübersicht für Kallikrein 15 Antikörper (ABIN6569346)
Target
Alle Kallikrein 15 (KLK15) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein of human KLK15 (NP_059979.2).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:500-1:2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- Kallikrein 15 (KLK15) (Kallikrein-Related Peptidase 15 (KLK15))
-
Andere Bezeichnung
- KLK15
-
Hintergrund
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. In prostate cancer, this gene has increased expression, which indicates its possible use as a diagnostic or prognostic marker for prostate cancer. The gene contains multiple polyadenylation sites and alternative splicing results in multiple transcript variants encoding distinct isoforms.
-
Molekulargewicht
-
Observed_MW: 28kDa
Calculated_MW: 13kDa/17kDa/19kDa/28kDa
-
Gen-ID
- 55554
-
UniProt
- Q9H2R5
-
Pathways
- Komplementsystem
Target
-